Compare CURI & RPID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CURI | RPID |
|---|---|---|
| Founded | N/A | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Movies/Entertainment | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 221.5M | 204.3M |
| IPO Year | N/A | 2021 |
| Metric | CURI | RPID |
|---|---|---|
| Price | $3.62 | $4.13 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 2 |
| Target Price | $6.00 | ★ $8.00 |
| AVG Volume (30 Days) | ★ 635.7K | 311.8K |
| Earning Date | 03-10-2026 | 02-27-2026 |
| Dividend Yield | ★ 8.84% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $66,595,000.00 | $30,523,000.00 |
| Revenue This Year | $42.19 | $19.36 |
| Revenue Next Year | $7.94 | $21.48 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 28.62 | 16.63 |
| 52 Week Low | $1.99 | $1.10 |
| 52 Week High | $7.15 | $4.88 |
| Indicator | CURI | RPID |
|---|---|---|
| Relative Strength Index (RSI) | 41.80 | 59.15 |
| Support Level | $3.54 | $2.92 |
| Resistance Level | $3.90 | $4.88 |
| Average True Range (ATR) | 0.19 | 0.38 |
| MACD | 0.03 | 0.15 |
| Stochastic Oscillator | 52.90 | 61.22 |
CuriosityStream Inc is a media and entertainment company. It offers premium video programming across the principal categories of factual entertainment, including science, history, society, nature, lifestyle, and technology. Its mission is to provide premium real entertainment that informs, enchants, and inspires. Its product and services are Direct to Consumer Business, Partner Direct Business, Bundled Distribution, Content Licensing, Enterprise Subscriptions and Others. The majority of the revenue comes from the Direct to direct-to-consumer business.
Rapid Micro Biosystems Inc is an life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company's flagship Growth Direct platform automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in the pharmaceutical manufacturing operations across the globe. It derives revenue from development, manufacturing, marketing and selling Systems and related LIMS connection software, consumables and services.